These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 13917379)

  • 1. Persistent immunity following Enders live, attenuated measles-virus vaccine given with human immune globulin.
    STOKES J; HILLEMAN MR; WEIBEL RE; BUYNAK EB; HALENDA R
    N Engl J Med; 1962 Aug; 267():222-4. PubMed ID: 13917379
    [No Abstract]   [Full Text] [Related]  

  • 2. Enders' live measles-virus vaccine with human immune globulin. I. Clinical reactions.
    STOKES J; WEIBEL R; HALENDA R; REILLY CM; HILLEMAN MR
    Am J Dis Child; 1962 Mar; 103():366-72. PubMed ID: 13917382
    [No Abstract]   [Full Text] [Related]  

  • 3. Administration of Enders' live measles virus vaccine with human immune globulin.
    WEIBEL R; HALENDA R; STOKES J; HILLEMAN MR; BUYNAK EB
    JAMA; 1962 Jun; 180():1086-94. PubMed ID: 14005592
    [No Abstract]   [Full Text] [Related]  

  • 4. Ender's live measles-virus vaccine with human immune globulin. II. Evaluation of efficacy.
    HILLEMAN MR; STOKES J; BUYNAK EB; WEIBEL R; HALENDA R; GOLDNER H
    Am J Dis Child; 1962 Mar; 103():372-9. PubMed ID: 13907410
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies with live attenuated measles-virus vaccine. Comparative clinical, antigenic, and prophylactic effects after inoculation with and without gamma-globulin.
    KRUGMAN S; GILES JP; JACOBS AM; FRIEDMAN H
    Am J Dis Child; 1962 Mar; 103():353-63. PubMed ID: 14459920
    [No Abstract]   [Full Text] [Related]  

  • 6. [Measles vaccination. Israeli studies with live attenuated measles virus vaccine and gamma globulin].
    LEVIN S; MOSES S; SHIMANSKY L; KRUGMAN S
    Harefuah; 1962 Sep; 63():161-6. PubMed ID: 14464579
    [No Abstract]   [Full Text] [Related]  

  • 7. Attenuated measles-virus vaccine studies in Israel. I. Comparison of reactions after inoculation of vaccine with gamma-globulin.
    LEVIN S; MOSES S; SHIMANSKY L; KRUGMAN S
    Am J Dis Child; 1962 Mar; 103():363-5. PubMed ID: 14464578
    [No Abstract]   [Full Text] [Related]  

  • 8. WHO-supported comparative studies of attenuated live measles virus vaccines.
    Cockburn WC; Pecenka J; Sundaresan T
    Bull World Health Organ; 1966; 34(2):223-31. PubMed ID: 4161187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COMBINED USE OF HUMAN GAMMA-GLOBULIN AND LIVE MEASLES-VIRUS VACCINE WITH REFERENCE TO SINGLE INOCULATION OF LIVE MEASLES-VIRUS VACCINE IN EARLY INFANCY.
    FUJII R; MINAMITANI M; NAKAMURA K
    Jpn J Med Sci Biol; 1965 Feb; 18():56-64. PubMed ID: 14300295
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on immunity to measles. II. Prophylactic and serological studies on the use of live and attenuated measles-virus vaccine].
    Egami T
    Kumamoto Igakkai Zasshi; 1966 May; 40(5):539-62. PubMed ID: 4164172
    [No Abstract]   [Full Text] [Related]  

  • 11. RESPONSE OF VOLTA CHILDREN TO LIVE ATTENUATED MEASLES VIRUS VACCINE.
    MEYER HM; HOSTETLER DD; BERNHEIM BC; ROGERS NG; LAMBIN P; CHASSARY A; SMADEL JE
    Bull World Health Organ; 1964; 30(6):769-81. PubMed ID: 14215184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RESPONSE OF ADULTS IN ICELAND TO LIVE ATTENUATED MEASLES VACCINE.
    GUDNADOTTIR M; BLACK FL
    Bull World Health Organ; 1964; 30(6):753-62. PubMed ID: 14215182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUPPRESSION OF MEASLES 19S ANTIBODY FORMATION AS EVIDENCE OF IMMUNITY. PRIMARY IMMUNE RESPONSE MASKED BY MATERIAL ANTIBODY.
    SCHLUEDERBERG A; KARELITZ S
    JAMA; 1965 Mar; 191():1064-6. PubMed ID: 14267895
    [No Abstract]   [Full Text] [Related]  

  • 14. A CONTROLLED TRIAL OF LIVER-VIRUS VACCINE AGAINST MEASLES IN CHILE.
    RISTORI C; BOCCARDO H; MIRANDA M; BORGONO M
    Bull World Health Organ; 1964; 30(6):763-8. PubMed ID: 14215183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DURABLE IMMUNITY TWO YEARS AFTER ADMINISTRATION OF ENDERS'S LIVE MEASLES-VIRUS VACCINE WITH IMMUNE GLOBULIN.
    WEIBEL RE; STOKES J; HALENDA R; BUYNAK EB; HILLEMAN MR
    N Engl J Med; 1964 Jan; 270():172-5. PubMed ID: 14068089
    [No Abstract]   [Full Text] [Related]  

  • 16. GLOBULIN-MODIFIED VACCINATION WITH LIVE ATTENUATED MEASLES VIRUS, SUGIYAMA, ADAPTED TO BOVINE RENAL CELLS.
    MINAMITANI M; NAKAMURA K; SHINOZAKI T; TAKAHASHI T; FUJII R; SABURI Y; MATUMOTO M
    Jpn J Exp Med; 1964 Apr; 34():85-8. PubMed ID: 14171677
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoglobulins on measles vaccine inoculation or measles virus infection--particularly, on 2-mercaptoethanol sensitive and resistant antibodies.
    Arai M; Nakamura M
    Acta Paediatr Jpn; 1970 Dec; 12(2):9-15. PubMed ID: 4100594
    [No Abstract]   [Full Text] [Related]  

  • 18. MEASLES VACCINATION IN INFANTS. USE OF KILLED-LIVE COMBINATIONS.
    ALEXANDER ER; BANSMER CM; HARRIS ES; GILES B; SPARKS MJ
    Am J Dis Child; 1964 Nov; 108():470-8. PubMed ID: 14208407
    [No Abstract]   [Full Text] [Related]  

  • 19. VACCINATION OF INFANTS WITH LIVING ATTENUATED MEASLES VACCINE (EDMONSTON STRAIN) WITH AND WITHOUT GAMMA-GLOBULIN.
    BENSON PF; BUTLER NR; GOFFE AP; KNIGHT GJ; LAURENCE GD; MILLER CL; POLLOCK TM
    Br Med J; 1964 Oct; 2(5413):851-3. PubMed ID: 14185636
    [No Abstract]   [Full Text] [Related]  

  • 20. EXPERIENCE IN THE U.S.S.R. IN THE PREVENTION OF MEASLES BY USE OF LIVE VACCINE.
    BOYCHUK LM; SHIKINA ES; MESHALOVA VN; TAROS LY; AMINOVA MG; REVENOK ND; SAFAROV DI
    Ind Med Surg; 1965 Jan; 34():43-50. PubMed ID: 14267212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.